Co-delivery of nucleoside-modified mRNA and TLR agonists for cancer immunotherapy: Restoring the immunogenicity of immunosilent mRNA. (Q47813139)
Jump to navigation
Jump to search
scientific article published on 4 October 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Co-delivery of nucleoside-modified mRNA and TLR agonists for cancer immunotherapy: Restoring the immunogenicity of immunosilent mRNA. |
scientific article published on 4 October 2017 |
Statements
Co-delivery of nucleoside-modified mRNA and TLR agonists for cancer immunotherapy: Restoring the immunogenicity of immunosilent mRNA (English)
Stefaan C De Smedt
Laura Wayteck
Benedicte Descamps